United Capital Financial Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

United Capital Financial Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,601	Closed	-$59K	–	1233
2020 Q3	$59K	Hold	12,601	–	–	﹤0.01%	1127
2020 Q2	$77K	Hold	12,601	–	–	﹤0.01%	1152
2020 Q1	$29K	Hold	12,601	–	–	﹤0.01%	1159
2019 Q4	$58K	Hold	12,601	–	–	﹤0.01%	1336
2019 Q3	$49K	Hold	12,601	–	–	﹤0.01%	1268
2019 Q2	$76K	Hold	12,601	–	–	﹤0.01%	1418
2019 Q1	$173K	Hold	12,601	–	–	﹤0.01%	1286
2018 Q4	$113K	Hold	12,601	–	–	﹤0.01%	1239
2018 Q3	$176K	Hold	12,601	–	–	﹤0.01%	1267
2018 Q2	$199K	Sell	12,601 -9	-0.1%	-$157	﹤0.01%	1230
2018 Q1	$217K	Buy	12,610 +9	+0.1%	+$176	﹤0.01%	1211
2017 Q4	$276K	Hold	12,601	–	–	﹤0.01%	1145
2017 Q3	$516K	Hold	12,601	–	–	﹤0.01%	948
2017 Q2	$379K	Hold	12,601	–	–	﹤0.01%	1002
2017 Q1	$456K	Hold	12,601	–	–	﹤0.01%	933
2016 Q4	$631K	Buy	+12,601	New	+$662K	0.01%	872

Other funds holding FPRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

United Capital Financial Advisors's FPRX Position: Q4 2020 in Review

United Capital Financial Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2020, closing a stake of 12,601 shares — an estimated $59K sold.

United Capital Financial Advisors first reported a position in FPRX in Q4 2016 and held it in 16 quarters. The position peaked at $631K in Q4 2016. 125 funds tracked by Wall St. Rank hold FPRX as of Q4 2020.

United Capital Financial Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
United Capital Financial Advisors sold 12,601 Five Prime Therapeutics, Inc. shares in Q4 2020, an estimated $59K.
United Capital Financial Advisors first reported a position in Five Prime Therapeutics, Inc. in Q4 2016 and held it in 16 quarters.
United Capital Financial Advisors's Five Prime Therapeutics, Inc. position peaked at $631K in Q4 2016.
125 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2020.

Based on United Capital Financial Advisors's 13F filing for Q4 2020, filed 17 Feb 2021.